Clinical Trials on Interstitial Lung Diseases (ILD) in New Zealand
Total 6789 results
-
Rohit Aggarwal, MDBoehringer IngelheimRecruitingMyositis Associated Interstitial Lund Disease (MA-ILD)United States
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
Pulmonary Fibrosis FoundationUniversity of MichiganCompletedInterstitial Lung Disease (ILD) | Idiopathic Pulmonary Fibrosis (IPF)United States
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); Boehringer Ingelheim; Cystic...RecruitingSmoking | Smoking Cessation | Chronic Obstructive Pulmonary Disease (COPD) | Idiopathic Pulmonary Fibrosis (IPF) | Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD) | Scleroderma-Associated Interstitial Lung Disease (SSC-ILD)United States
-
Arrowhead PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisDenmark, United Kingdom, New Zealand, Spain
-
Monash UniversityRecruitingFibrotic Interstitial Lung DiseaseAustralia
-
Weill Medical College of Cornell UniversityNeuralpositiveCompletedInterstitial Lung DiseaseUnited States
-
AdAlta LimitedCompletedInterstitial Lung DiseaseAustralia
-
Wissenschaftliches Institut Bethanien e.VRoche Pharma AGCompleted
-
University Hospital, EssenMarta CuyásActive, not recruitingInterstitial Lung DiseaseGermany
-
Wissenschaftliches Institut Bethanien e.VCompleted
-
Columbia UniversityGenentech, Inc.Recruiting
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Iowa; Weill... and other collaboratorsCompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung DiseaseUnited States
-
Northwell HealthCompletedPulmonary Arterial Hypertension | Pulmonary Hypertension | Interstitial Lung DiseaseUnited States
-
Australian and New Zealand Intensive Care Research...Intensive Care Foundation, AustraliaCompletedCritically Ill Adults Ventilated >24 Hours in Intensive CareAustralia, New Zealand
-
University of California, San FranciscoCompletedInterstitial Lung DiseaseUnited States, Canada
-
Northwell HealthCompletedPulmonary Arterial Hypertension | Pulmonary Hypertension | Interstitial Lung DiseaseUnited States
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Diffuse Parenchymal Lung DiseaseUnited States
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
Middlemore Hospital, New ZealandUnknown
-
Mylan Inc.Theravance BiopharmaCompleted
-
Duke UniversityBoehringer IngelheimRecruitingIdiopathic Pulmonary Fibrosis, Interstitial Lung DiseaseUnited States, Puerto Rico
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
Icahn School of Medicine at Mount SinaiUniversity of Pittsburgh; Brigham and Women's Hospital; University of New Mexico and other collaboratorsActive, not recruitingLung Cancer | Interstitial Lung Disease | Chronic Airway DiseaseUnited States
-
University of OtagoCompleted
-
Lassen Therapeutics 1 PTY LTDRecruitingThyroid Eye Disease | Pulmonary FibrosisAustralia, New Zealand, Hong Kong
-
United TherapeuticsRecruitingInterstitial Lung Disease | Progressive Pulmonary FibrosisUnited States, Canada
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
-
Michael RothUniversity of California, Los Angeles; University of Michigan; Genentech, Inc.CompletedScleroderma, Systemic | Interstitial Lung DiseaseUnited States
-
Pharmosa Biopharm Inc.Novotech (New Zealand) LimitedNot yet recruitingPulmonary Arterial HypertensionNew Zealand
-
University of OtagoHealth Research Council, New ZealandCompleted
-
GlaxoSmithKlineCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedSystemic Sclerosis-associated Interstitial Lung DiseaseUnited States, Canada, Italy, Poland, Spain, Argentina, Australia, Israel, United Kingdom
-
GlaxoSmithKlineCompleted
-
Scleroderma Research Foundation, Inc.Sanofi; Boehringer IngelheimNot yet recruitingScleroderma | Interstitial Lung Disease Due to Systemic DiseaseUnited States
-
Brigham and Women's HospitalCompletedRheumatoid Arthritis Interstitial Lung DiseaseUnited States, Canada, Australia, United Kingdom
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Weill Medical College of Cornell UniversityCompletedAsthma | Lung Cancer | Cystic Fibrosis | Interstitial Lung Disease | COPDUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedIdiopathic Pulmonary Fibrosis | Pulmonary Arterial Hypertension | Pulmonary Hypertension | Interstitial Lung Disease | Sarcoidosis | Idiopathic Interstitial Pneumonia | Cryptogenic Organizing Pneumonia | Desquamative Interstitial Pneumonia | Respiratory Bronchiolitis Associated Interstitial Lung Disease and other conditionsUnited States, Germany
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
United TherapeuticsRecruitingIdiopathic Pulmonary Fibrosis | Interstitial Lung DiseaseTaiwan, Belgium, Spain, Korea, Republic of, Germany, Australia, Chile, Denmark, France, Mexico, Israel, Italy, Netherlands, Argentina, New Zealand, Peru
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand